MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinicopathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC). Methods: The present study investigated the correlation between MUC2 expression and clinicopathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs. Results: MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p = .001, p = .001, and p = .011, respectively). However, MUC2 expression was not correlated with Lauren’s classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren’s classification, pN stage, or pTNM stage. Conclusions: MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.
Abstract
Background: While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinicopathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC). Methods: The present study investigated the correlation between MUC2 expression and clinicopathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs. Results: MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p = .001, p = .001, and p = .011, respectively). However, MUC2 expression was not correlated with Lauren’s classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren’s classification, pN stage, or pTNM stage. Conclusions: MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.
참고문헌 (22)
- Ïlhan Ö, "Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma", Turk J Gastroenterol, 21, pp.345~352 (2010)
- 김주연, "Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes", Journal of Pathology and Translational Medicine, 47(1), pp.28~35 (2013), 대한병리학회
- Lee HS, "MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators", Cancer, 92, pp.1427~1434 (2001)
- Wakatsuki K, "Clinicopathological and prognostic significance of mucin phenotype in gastric cancer", J Surg Oncol, 98, pp.124~129 (2008)
- Busuttil RA, "Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis", J Gastroenterol Hepatol, 24, pp.193~201 (2009)
- Reis CA, "Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression", Cancer Res, 59, pp.1003~1007 (1999)
- Pyo JS, "Activation of nuclear factor-kappaB contributes to growth and aggressiveness of papillary thyroid carcinoma", Pathol Res Pract, 209, pp.228~232 (2013)
- Akyürek N, "Expression of MUC1 and MUC2 mucins in gastric carcinomas : their relationship with clinicopathologic parameters and prognosis", Pathol Res Pract, 198, pp.665~674 (2002)
- Baldus SE, "Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas", Int J Cancer, 79, pp.133~138 (1998)
- Barresi V, "Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren’s histologic subtypes of gastric carcinomas", Eur J Histochem, 50, pp.301~309 (2006)
- Lee HW, "Expression of MUC2 in gastric carcinomas and background mucosae", J Gastroenterol Hepatol, 22, pp.1336~1343 (2007)
- Shiratsu K, "Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach", Cancer Sci, 105, pp.126~133 (2014)
- Tanaka M, "Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy", Br J Surg, 90, pp.95~101 (2003)
- Utsunomiya T, "Expression of MUC1 and MUC2 mucins in gastric carcinomas : its relationship with the prognosis of the patients", Clin Cancer Res, 4, pp.2605~2614 (1998)
- Wang RQ, "Alterations of MUC1 and MUC3 expression in gastric carcinoma : relevance to patient clinicopathological features", J Clin Pathol, 56, pp.378~384 (2003)
- Zhang HK, "Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance", World J Gastroenterol, 10, pp.3044~3047 (2004)
- Audie JP, "Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization", J Histochem Cytochem, 41, pp.1479~1485 (1993)
- Chang SK, "Localization of mucin(MUC2 and MUC3)messenger RNA and peptide expression in human normal intestine and colon cancer", Gastroenterology, 107, pp.28~36 (1994)
- Kocer B, "Prognostic significance of mucin expression in gastric carcinoma", Dig Dis Sci, 49, pp.954~964 (2004)
- Pyo JS, "Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas", J Cancer Res Clin Oncol (2014)[DOI]
- Li L, "Clinicopathological significance of mucin 2 immuno-histochemical expression in colorectal cancer : a meta-analysis", Chin J Cancer Res, 24, pp.190~195 (2012)
- Gong L, "Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis", Clin Transl Sci, 2, pp.286~293 (2009)